-
1. Tissue biopsy for the diagnosis of amyloidosis: experience from some centres. Amyloid, 2022 (in press)
Benson MD, Berk JL, Dispenzieri A, Damy T, Gillmore JD, Hazenberg BP, Lavatelli F, Picken MM, Röcken C, Schönland S, Ueda M, Westermark P.
-
2. Age-related amyloidosis outside the brain: A state-of-the-art review. Ageing Research Reviews, 70: 101388, 2021
Tasaki M, Lavatelli F*, Obici L, Obayashi K, Miyamoto T, Merlini G, Palladini G, Ando Y, Ueda M*.
-
3. Apolipoprotein AI amyloid deposits in the ligamentum flavum in patients with lumbar spinal canal stenosis. Amyloid, 2021;28:107-112.
Tasaki M, Okada M, Yanagisawa A, Nomura T, Ueda A, Inoue Y, Masuda T, Misumi Y, Yamashita T, Miyamoto T, Obayashi K, Ando Y, Ueda M.*
-
4. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol, 2021;20:49-59.
Adams D, Polydefkis M, Gonzalez-Duarte A, Wixner J, Kristen A, Schmidt H, Berk J, López I, Dispenzieri A, Conceiçao I, Slama M, Gillmore J, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei M, Plante-Bordeneuve V, Attarian S, Mauricio E, Brannagan T, Ueda M, Aldinc E, Wang J, White M, Vest J, Berber E, Sweetser M, Coelho T.
-
5. JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis. Circ J, 2020;84:1610-1671.
Kitaoka H, Izumi C, Izumiya Y, Inomata T, Ueda M, Kubo T, Koyama J, Sano M, Sekijima Y, Tahara N, Tsukada N, Tsujita K, Tsutsui H, Tomita T, Amano M, Endo J, Okada A, Oda S, Takashio S, Baba Y, Misumi Y, Yazaki M, Anzai T, Ando Y, Isobe M, Kimura T, Fukuda K; Japanese Circulation Society Joint Working Group.
-
6. Monitoring of asymptomatic family members at risk of hereditary transthyretin amyloidosis for early intervention with disease-modifying therapies. J Neurol Sci, 2020;414:116813.
Ueda M,* Sekijima Y, Koike H, Yamashita T, Yoshinaga T, Ishii T, Ando Y.
-
7. Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. J Neurol, 2020;267:703-712.
González-Duarte A, Berk J, Quan D, Mauermann M, Schmidt H, Polydefkis M, Waddington-Cruz M, Ueda M, Conceição I, Kristen A, Coelho T, Cauquil C, Tard C, Merkel M, Aldinc E, Chen J, Sweetser M, Wang J, Adams D.
-
8. Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis. Neurology, 2019;93:714-716.
Yamashita T, Ueda M, Nomura T, Okazaki T, Okada M, Tsuda Y, Inoue Y, Masada T, Misumi Y, Takamatsu K, Obayashi K, Inomata Y, Hibi T, Ando Y.
-
9. Nationwide survey on cerebral amyloid angiopathy in Japan. Eur J Neurol, 2019;26:1487-1493.
Sakai K, Ueda M, Fukushima W, Tamaoka A, Shoji M, Ando Y, Yamada M.
-
10. A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH. J Biol Chem, 2019;294:11259-11275.
Ueda M, Okada M, Mizuguchi M, Kluve-Beckerman B, Kanenawa K, Isoguchi A, Misumi Y, Tasaki M, Ueda A, Kanai A, Sasaki R, Masuda T, Inoue Y, Nomura T, Shinriki S, Shuto T, Kai H, Yamashita T, Matsui H, Benson M, Ando Y.
-
11. New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis. Orphanet J Rare Dis, 2019;14:116.
Nomura T, Ueda M, Tasaki M, Misumi Y, Masuda T, Inoue Y, Tsuda Y, Okada M, Okazaki T, Kanenawa K, Isoguchi A, Nakamura M, Obayashi K, Shinriki S, Matsui H, Yamashita T, Ando Y.
-
12. Characteristics of acquired transthyretin amyloidosis A case series and review of the literature. Neurology, 2019;93:e1587-e1596.
Misumi Y, Ueda M, Masuda T, Tsuda Y, Nomura T, Okada M, Inoue Y, Tasaki M, Obayashi K, Yamashita T, Ando Y.
-
13. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid, 2019;26:3-9.
Conceição I, Damy T, Romero M, Galán L, Attarian S, Luigetti M, Sadeh M, Sarafov S, Tournev I, Ueda M.
-
14. Extreme adhesion activity of amyloid fibrils induces subcutaneous insulin resistance. Diabetes, 2019;68:609-616.
Nakamura M, Misumi Y, Nomura T, Oka W, Isoguchi A, Kanenawa K, Masuda T, Yamashita T, Inoue Y, Ando Y, Ueda M.
-
15. A novel age-related venous amyloidosis derived from EGF-containing fibulin-like extracellular matrix protein 1. J Pathol, 2019;247:444-455 (*contributed equally).
Tasaki M,* Ueda M,* Hoshii Y, Mizukami M, Matsumoto S, Nakamura M, Yamashita T, Ueda A, Misumi Y, Masuda T, Inoue Y, Torikai T, Nomura T, Tsuda Y, Kanenawa K, Isoguchi A, Okada M, Matsui H, Obayashi K, Ando Y.
-
16. Patisiran, a RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med, 2018;379:11-21.
Adams D, Gonzalez-Duarte A, O’Riordan W, Yang C, Ueda M, Kristen A, Tournev I, Schmidt H, Coelho T, Berk J, Lin K, Vita G, Attarian S, Plante-Bordeneuve V, Mezei M, Campistol J, Buades J, Brannagan T, Kim B, Oh J, Parman Y, Sekijima Y, Hawkins P, Solomon S, Polydefkis M, Dyck P, Gandhi P, Goyal S, Chen J, Strahs A, Nochur S, Sweetser M, Garg P, Vaishnaw A, Gollob J, Suhr O.
-
17. First Nationwide Survey on Wild-type ATTR Amyloidosis in Japan. Amyloid, 2018;25:8-10.
Sekijima, Y, Yazaki M, Ueda M, Koike H, Yamada M, Ando Y.
-
18. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. J Neurol, 2018;265:134-140.
Yamashita T, Ueda M, Misumi Y, Masuda T, Nomura T, Tasaki M, Takamatsu K, Sasada K, Obayashi K, Matsui H, Ando Y.
-
19. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy. Acta Neuropathol, 2017;134:605-617.
Inoue Y, Ueda M, Tasaki M, Takeshima A, Nagatoshi A, Masuda T, Misumi Y, Kosaka T, Nomura T, Mizukami M, Matsumoto S, Yamashita T, Takahashi H, Kakita A, Ando Y.
-
20. Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy. Neurology, 2017;88:2192–2197.
Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y.
-
21. Novel screening for transthyretin amyloidosis by using fat ultrasonography. Ann Neurol, 2017;81:604-608.
Misumi Y, Ueda M, Yamashita T, Masuda T, Kinoshita Y, Tasaki M, Nagase T, Ando Y.
-
22. Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid. Amyloid, 2016;23:26-32.
Yanagisawa A, Ueda M, Sueyoshi T, Nakamura E, Tasaki M, Suenaga G, Motokawa H, Toyoshima R, Kinoshita Y, Misumi Y, Yamashita T, Sakaguchi M, Westermark P, Mizuta H, Ando Y.
-
23. Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014. J Neurol, 2015;262:1828-1836.
Ueda A, Ueda M, Nagatoshi A, Hirano T, Ito T, Arai N, Uyama E, Mori K, Nakamura M, Shinriki S, Ikeda K, Ando Y.
-
24. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Mod Pathol, 2015;28:201-207.
Yanagisawa A, Ueda M, Sueyoshi T, Okada T, Fujimoto T, Ogi Y, Kitagawa K, Tasaki M, Misumi Y, Oshima T, Jono H, Obayashi K, Hirakawa K, Uchida H, Westermark P, Ando Y, Mizuta H.
-
25. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation. J Neurol Neurosurg Psychiatry, 2014;85:740-746. (*contributed equally)
Oshima T,* Kawahara S,* Ueda M,* Kawakami Y, Tanaka R, Okazaki T, Misumi Y, Obayashi K, Yamashita T, Ohya Y, Ihse E, Shinriki S, Tasaki M, Jono H, Asonuma K, Inomata Y, Westermark P, Ando Y.
-
26. Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy. Neurology, 2012;78:637-643.
Yamashita T, Ando Y, Okamoto S, Misumi Y, Hirahara T, Ueda M, Obayashi K, Nakamura M, Jono H, Shono M, Asonuma K, Inomata Y, Uchino M.
-
27. Aged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: A valid pathological model of the human disease. Lab Invest, 2012;92:474-484.
Ueda M, Ageyama N, Nakamura S, Nakamura M, Chambers J, Misumi Y, Mizuguchi M, Shinriki S, Kawahara S, Tasaki M, Jono H, Obayashi K, Sasaki E, Une Y, Ando Y.
-
28. Clinicopathological features of senile systemic amyloidosis: an ante- and postmortem study. Mod Pathol, 2011;24:1533-1544. (*contributed equally).
Ueda M*, Horibata Y*, Shono M, Misumi Y, Oshima T, Su Y, Tasaki M, Shinriki S, Kawahara S, Jono H, Obayashi K, Ogawa H, Ando Y.
-
29. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. Hum Pathol, 2011;42:1259-1264.
Sueyoshi T, Ueda M, Jono H, Irie H, Sei A, Ide J, Ando Y, Mizuta H.
-
30. SELDI-TOF MS evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy. Clin Chem 2009;55:1223-7
Ueda M, Misumi Y, Mizuguchi M, Nakamura M, Yamashita T, Sekijima Y, Ota K, Shinriki S, Jono H, Ikeda SI, Suhr OB, Ando Y.
